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Background: Status epilepticus (SE) is a medical emergency that requires immediate action. The clinical and
demographic features of SE are known to be highly variable. The objective of this study was to analyze the effect of
treatment delays on patient recovery and different clinical factors that are important in the determination of the
acute prognosis in SE.
Methods: This population-based study included 109 consecutive visits of patients with the diagnosis of SE in the
emergency department (ED) of Tampere University Hospital. The clinical features of SE were compared with the
discharge condition.
Results: The treatment delays were long; in half of the patients, the delay for paramedic arrival was over 30 min,
and in one-third of the cases, the delay was over 24 h. ED patients who had less than 1 h of delay before the
administration of an antiepileptic drug (AED) had better outcomes compared to patients with a greater than 1 h
delay (p < 0.05). The two major etiologies for the SE were cerebrovascular disease and alcohol misuse. A good
immediate outcome was found in 46% of the patients. Epileptiform activity on the EEG, a history of epilepsy or SE,
presence of cardiovascular disease, and alcohol misuse were associated with a poor outcome.
Conclusions: The results of this study emphasize the importance of an urgent response by emergency services and
proper recognition of atypical phenotypes of SE.
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Status epilepticus (SE) is a medical emergency that
requires rapid diagnosis and treatment. Both clinical
studies and empirical experience indicate a variation in
treatment practices and treatment delays in prolonged
seizures. A Finnish study of 157 children strengthened
the previously known association between treatment
delays and outcomes [1]. Earlier studies have shown the
impact of age on the outcome of SE, children having
better chances of recovery [2]. The etiology of SE is also
associated with prognosis [3]. Acute symptomatic causes
(= acute cerebral insults with seizures) and cerebrovas-
cular disease as the etiology worsen the prognosis [4].* Correspondence: suvi.liimatainen@fimnet.fi
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in any medium, provided the original work is pIn this study, we evaluated treatment delays, different
clinical features of the SE, and the use of antiepileptic
drugs (AED) for prolonged seizures and their association
with patient recovery. All adult patients with prolonged
seizures in the Pirkanmaa Hospital District (population
of 440,000), except those patients already hospitalized in
our hospital, are treated in our emergency department
(ED). For this reason, the present study represents
population-based treatment practices of EDs in Finland.Methods
Patients
This study was a retrospective, population-based study
of 109 consecutive visits (100 patients) of adult patients
with a diagnosis of status epilepticus (SE) (ICD10 code
G41.0–41.9) who were treated in the ED of Tampere
University Hospital between 1 May 2007 and 23 November
2009. We aimed to obtain a maximal number of
patients to explore the clinical treatment practices. TheOpen Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
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were excluded from the study because there is a separate
pediatric ED in our hospital. The medical records of all
the patients that met the diagnosis of SE were reviewed
to identify the clinical features that affected the current
episode. We used an established definition of SE: a seiz-
ure lasting ≥ 30 min or recurring seizures without full
recovery between seizures [5,6]. These previous studies
suggest SE lasting over 30 min increases the mortality
rate [5,6]. The study protocol followed the guideline
of Declaration of Helsinki and STROBE statement.
The study was approved by the Ethics Committee of
Tampere University Hospital.
Treatment delay
The treatment delay was calculated based on the time of
the beginning of the seizure (if known), the arrival of
paramedics, the initiation of AED treatment out of hos-
pital and in the ED, and the arrival at the ED. In patients
for whom the beginning of the seizure was unknown, we
estimated the duration based on available data from
eyewitnesses, relatives, and nursing personnel.
Co-morbidity
Previous disorders, such as previous brain disease [e.g.,
epilepsy, dementia, stroke, tumor, and central nervous
system (CNS) infection], psychiatric disease, cardiovas-
cular disease, diabetes, traumatic episodes, misuse of al-
cohol or drugs, and other diseases, as well as the history
of SE, were recorded.
Assessment of neurological condition
Neurological parameters
The following parameters were recorded: convulsions in
any part of the body; psychomotor slowness; disorienta-
tion; confusion; aphasia; pupillary reflex; unilateral sen-
sorimotor deficit in the face, arm or leg; deviation of the
head and eyes; neglect; nystagmus; and other findings.
The Glasgow Coma Scale (GCS) score was recorded.
Seizure classification
The seizure type was categorized as unclassified gen-
eralized, secondary generalized, complex partial, and sim-
ple partial according to the International League Against
Epilepsy (ILAE) classification [7]. The seizures were classi-
fied as secondary generalized (SGSE) based on the epilepsy
history, seizure semiology, and neurological condition when
there were signs of focal onset of the seizure or a focal le-
sion in the neuroimaging that correlated with the seizure
type. In the rest of the patients with generalized seizures,
the seizure type was classified as unclassified generalized
(GSE); in these patients, focal onset could not be confirmed.
Complex partial SE (CPSE) included seizures where con-
sciousness was impaired, with or without motor signs.Because of the inclusion criterion that the study patients
were first treated in the ED, there were no patients with
postresuscitation myoclonic jerks.
Etiology of SE
The etiology of the SE was classified as cerebrovascular
disease, brain tumor, traumatic brain injury (TBI), CNS
infection, alcohol, structural lesion, other, or unknown.
The majority of the patients with epilepsy used newer
AEDs that do not require monitoring of blood drug
levels. Furthermore, there was no definitive evidence
that low drug levels were the cause of SE in any of the
study patients. For these reasons, we could not consider
low blood concentrations of an AED to be the main
underlying cause of SE in any of the study patients. We
categorized the underlying causes of SE as acute symp-
tomatic, remote symptomatic, probably symptomatic, or
idiopathic depending on the patient history and the
results of the neuroimaging and lumbar puncture, when
performed.
Imaging studies and electroencephalograph (EEG)
We analyzed the results of acute neuroimaging [brain
computer tomography scanning (CT) or magnetic reson-
ance imaging (MRI)] and the findings of the 21-channel
emergency EEG, when performed.
Medication
Medications taken by the patients in the study included
levetiracetam (13 patients), valproic acid (14 patients),
carbamazepine (7 patients), oxcarbazepine (7 patients),
topiramate (6 patients), lamotrigine (5 patients), pregabalin
(4 patients), phenytoin (3 patients), gabapentin (1 patient),
and lacosamide (1 patient). Additionally, the use of ben-
zodiazepines, antipsychotics, antidepressants, or other
medications was evaluated.
The treatment protocol for SE consisted of first- (di-
azepam or lorazepam), second- (phosphenytoin, valproic
acid, or levetiracetam), third- (propofol, midazolam or
thiopenthal), and fourth-line (topiramate) AEDs. The
AED treatment was recorded, including the time from
the beginning of the seizure to the initiation of the drug
intervention, the treatment response to each drug, and
the time from the initiation of the treatment to the end
of the seizure.
Outcome
The immediate outcome was estimated by classifying the
neurological condition into one of the following groups
using a slightly modified Rankin Scale, a scale used to
assess level of function in neurological disorder: good
recovery (no symptoms or no significant disability; able
to carry out usual activities, despite some symptoms),
slight disability (able to look after own affairs without






Acute symptomatic 39 35.8
Remote symptomatic 54 49.5
Probably symptomatic or idiopathic 16 14.7
Type of seizure





Not known 2 1.8





Generalized epileptiform activity 11 10.0
Focal epileptiform activity 22 20.2
General slowing 18 16.5
Focal slowing 14 12.8
Normal 4 3.7
Not performed 40 36.7
Discharge condition
Normal 21 19.2
Minor disability 29 26.6
Moderate disability 33 30.3




Time in hospital (days, mean/range) 8.06/range 2–31
Intubation 23 21
Late recurrence
Same period 1 0.9
Later 31 28
GSE, generalized status epilepticus; SGSE, secondarily generalized status
epilepticus; SPSE, simple partial status epilepticus; CPSE, complex partial status
epilepticus; MSE, myoclonic status epilepticus; EEG, electroencephalograph.
Acute symptomatic etiology of seizure means condition with acute cerebral
insult with seizures.
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moderate disability (requires some help, but able to walk
unassisted), severe disability (unable to attend to one’s
own bodily needs without assistance, and unable to walk
unassisted or requires constant nursing care and atten-
tion, bedridden, incontinent), death, or unknown [8,9].
Any relapses of seizures in the hospital, as well as later
relapses during the study period, were recorded.
Data analysis
Statistical differences between categorical variables were
tested using Pearson’s chi-squared test. A binomial logis-
tic regression model was used to evaluate the prognostic
value (OR) of the categorical factors to the outcome and
later seizure recurrence. The treatment delays were
analyzed as non-parametric variables and were presented




The clinical characteristics of the study patients are
presented in Table 1. Females comprised 45% of the
patients; the mean age was 62.6 years (range 17–89
years). In the patient population, 43% had epilepsy, and
32% has previous episodes of SE. In addition, 32% had
cerebrovascular disease, 4.5% had dementia, 3.7% had a
brain tumor, and 1.8% had a CNS infection.
Treatment delays and outcome
The median delay for paramedic arrival was 30 min, ini-
tiation of out-of-hospital AEDs 1 h 10 min, arrival at the
ED 1 h 45 min, and initiation of AED in the ED 2 h 11
min. To evaluate the effect of treatment delays on out-
come, patients were classified according to delays as
follows: arrival of paramedics and initiation of out-of
-hospital AEDs in (1) less than 30 min, (2) 30 min to 1
h, or (3) more than 1 h (up to 96 hours). The delay be-
tween arrival at the ED and initiation of AEDs in the
hospital was classified as follows: (1) less than 1 h, (2)
greater than 1 h but less than 24 h, or (3) 24 h or more
(up to 96 h). The outcome was classified as follows:
good (normal or minor disability) or poor (moderate or
severe disability or death). The distribution of patients in
these groups according to outcome is presented in
Figures 1, 2, 3, and 4.
We found no significant differences in the patient out-
come with respect to treatment delays (Figure 1), except
that patients for whom emergency AED treatment was
initiated in the ED within 1 h of seizure onset showed
good recovery in 82% (9 out of 11) of cases, whereas
only 46% of patients for whom AED treatment was
initiated more than 1 h after the seizure onset had a
good outcome (p < 0.05, Pearson’s chi-square test).
Figure 1 The delay of paramedic arrival and patient outcome. Outcome was classified as good (normal or minor disability) or poor
(moderate or severe disability or death).
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The etiology of the seizure was cerebrovascular disease
in 41.2%, alcohol misuse in 18.3%, trauma in 5.5%, infec-
tion in 5.5%, tumor in 4.6%, structural anomaly in 1.8%,
other in 16.5%, and unknown in 6.4% of the cases. We
investigated the effect of clinical variables on the out-
come by categorizing the outcome condition into two
classes: good (normal or minor disability) or poor (mod-
erate or severe disability or death). The presence of car-
diovascular disease was associated with a poor outcome
(OR 2.28, 95% CI: 1.04–4.96; p = 0.039); 36% of the
patients with cardiovascular disease had a good out-
come, and 64% had a poor outcome (compared to 56%
and 44% of patients without cardiovascular disease, re-
spectively). Epileptiform activity in an EEG examinationFigure 2 The delay in out-of-hospital AED initiation and patient outco
poor (moderate or severe disability or death).was associated with a poor outcome (OR 3.00, 95% CI:
1.11–8.1; p = 0.028). For further analysis, we grouped the
etiology of SE into three categories: cerebrovascular dis-
ease, alcohol misuse, and other. No statistical differences
in outcome were found between the groups. Furthermore,
there were no differences between generalized seizure and
other seizure types with respect to the outcome. Interest-
ingly, whether the beginning of the seizure was observed
was not associated with disability.
Categorical factors predicting seizure recurrence
A history of epilepsy was associated with the rate of seiz-
ure recurrence (OR 3.37, 95% CI: 1.41–8.05; p = 0.006).
Additionally, a history of SE was associated with the risk
of seizure recurrence (OR 6.04, 95% CI: 2.43–14.97;me. Outcome was classified as good (normal or minor disability) or
Figure 3 The delay in arrival at the ED and patient outcome. Outcome was classified as good (normal or minor disability) or poor (moderate
or severe disability or death).
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recurrence (OR 3.765, 95% CI: 1.55–9.14; p = 0.003), but
it did not have an effect on disability; the outcome was
good in 35% and poor in 65% of the cases (n = 20). The
presence of diabetes or CNS disease did not have an ef-
fect on disability.
Medication
Benzodiazepine given out of hospital did not have an ef-
fect on the outcome or rate of seizure recurrence.
Epileptiform activity in the EEG was more common
among those who did not get benzodiazepines out of hos-
pital; there were discharges in the EEG of 41% of patients
in the benzodiazepine group and 56% of patients in the
non-benzodiazepine group, but the difference was not
statistically significant. The type of AED given firstFigure 4 The delay in AED initiation and patient outcome. Outcome w
severe disability or death).(lorazepam, diazepam, or phosphenytoin) in the ED did
not seem to associate with findings in the EEG, the out-
come, or seizure recurrence rate. The proportion of AEDs
given in the ED was as follows: lorazepam, 59 patients; di-
azepam, 26; phosphenytoin, 72; levetirasetam, 6; valproic
acid, 3; oxcarbazepine, 1; and propofol, 11.
Findings in brain CT examinations, the type of seizure,
the etiology of SE, and the general condition of the pa-
tient in the out-of-hospital period were not associated
with the outcome. The GCS before the patient was
brought into the ED did not have an effect on the dis-
ability or later relapses. Six patients died in the hospital
during the SE period. Three of those patients had an
acute stroke, one had Down syndrome and epilepsy, one
had misused alcohol, and one had an acute myocardial
infarction.as classified as good (normal or minor disability) or poor (moderate or
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Current guidelines for treating SE emphasize immediate
action to interrupt the seizure. However, in real life, sev-
eral variables interfere with optimal treatment. The
treatment delay in this study was surprisingly high in
both patients with known, but specifically with un-
known, duration of the seizure. Regardless, the delays
were not associated with the disability of the patients.
This surprising finding is partly explained by the fact
that all of the patients had a severe condition. It is worth
noting that a remarkable proportion of the patients (56
cases) did not get any out-of-hospital drug treatment.
These patients either did not have visible convulsions or
the convulsions were intermittent. When evaluating the
group with a known duration of the seizure, the treat-
ment delays were shorter but still quite long. The delay
is at least partly explained by the long distances between
hospitals and the populations that they serve in Finland.
Due to several factors, it was impossible to quantify the
exact duration of SE. The retrospective nature of this
study made it difficult to determine the duration of the
SE based on medical records. Even in the clinical setting,
determination of the exact time to recovery and the
treatment response is challenging, especially in patients
with NCSE.
We analyzed several clinical characteristics that are
important to accurately evaluate the acute outcome of
patients with SE. From a clinical point of view, the com-
mon opinion that a primary or secondary generalized
seizure has a more severe influence on recovery was not
confirmed in the present study. Manifestations of SE are
highly diverse, and outcomes are influenced by different
variables. Epileptiform activity in the EEG was associated
with a poor outcome, which supports the importance of
an EEG examination in the ED. With this in mind, an
EEG could be regarded as the most important prognos-
tic biomarker when evaluating the prognosis of a patient
with SE. This finding supports the need for an immedi-
ate EEG evaluation in all patients with SE [10].
The etiology of SE did not have an effect on the out-
come. The two major etiologies in this study were cere-
brovascular disease and alcohol misuse. Both acute
symptomatic and remote symptomatic seizures caused
by stroke are known to be associated with an increased
risk of long-term mortality [11]. The immediate progno-
sis of SE, and especially GCSE, seems to be poor in
post-stroke epilepsy [12,13]. The misuse of alcohol, espe-
cially during withdrawal from drinking, is a common
problem in the ED. The prognosis of these patients
depends on other risk factors, such as TBI and metabolic
problems. External toxicological agents, the elimination
of which may improve prognosis, primarily cause pure
withdrawal seizures. In a study of 249 patients with
GCSE, alcohol was the major cause of SE in 10.8% ofthe patients [14]. The overall prognosis was favorable, al-
though there were patients with prolonged postictal
state. The sample size was not sufficient to answer the
question about the variables affecting the outcome of
different disease groups. However, it is possible that
those patients with alcohol-related seizures had under-
lying although unknown precipitating factors worsening
the prognosis. In addition, we did not have a possibility
to evaluate the long-term prognosis of these patients.
The small proportion of patients with TBI in the
present study is explained by the fact that, in TBI
patients, the SE is usually a secondary complication of
the primary disorder. We did not find patients with low
AED blood concentrations in this study. This problem
as an underlying cause of SE is difficult to prove because
the majority of epilepsy patients use new AEDs, which
do not require monitoring of the blood concentrations.
However, the measurement of serum drug levels in the
treatment of SE would be important in evaluating the
possibility of non-compliance and other causes of inad-
equate AED dose. In a previous study, the long-term
mortality rate was higher in patients with acute symp-
tomatic SE, but that study differed from ours because it
included patients with myoclonic SE after anoxic en-
cephalopathy [15]. In 15% of the patients, the underlying
etiology of SE was regarded as probably symptomatic or
idiopathic, which matches the findings in the Minnesota
study (17.5%) [16]. We included only patients with a
diagnosis of SE upon admission to the hospital but not
patients with anoxia. The existence of cardiovascular
disease was associated with a worse outcome: two-thirds
of the patients with cardiovascular disease had poor out-
come. This finding supports the use of a holistic per-
spective in evaluating patients in the acute setting.
The impact of the first-line treatment in the out-of
-hospital stage was surprisingly small. There were no
differences in disability or later relapses between the
patients with or without treatment at the out-of-hospital
stage. However, in all of the study patients, SE was
treated very aggressively immediately upon arrival at the
ED. We did not find any differences between the various
first-line AEDs administered in the ED. In the present
study, there were no patients receiving intramuscular
midazolam, which has proved effective compared with
intravenous administration of lorazepam [17].
There are some weaknesses of this study. The small
proportion of epilepsy patients with prolonged seizures
is diagnosed only with their chronic epilepsy diagnosis
number. Missing data on delays weaken the applicability
of the results; however, very long delays in a proportion
of patients warrants the need for development of the
emergency medicine system. We included only patients
with SE at admission to the ED, not those patients with
SE as a complication of their primary disease leading to
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concentrates on the treatment of the SE in the ED.
Conclusions
To conclude, this study demonstrates which clinical
factors are important in evaluating patients with SE in the
ED. Treatment delays could be shortened by increasing
paramedics’ understanding and knowledge of atypical SE
and by improving the quality of emergency medicine
services.
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